---
layout: full_article
title: "THE TAI CHI ROLES IN REDUCING FATIGUE, PAIN, AND TNF-a PLASMA LEVEL ON BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW"
author: "Putri Yekti Budi Asih, I Putu Edra Putra Indrawan, Andhika Putri Perdana, Putu Ratna Candra Puspita, Vera Pravitasari Susila, Nila Wahyuni, I Putu Gede Adiatmika"
categories: sport
canonical_url: https://jurnal.harianregional.com/sport/full-85045 
citation_abstract_html_url: "https://jurnal.harianregional.com/sport/id-85045"
citation_pdf_url: "https://jurnal.harianregional.com/sport/full-85045"  
comments: true
---

<p><span class="font0" style="font-weight:bold;">Sport and Fitness Journal</span></p>
<p><span class="font0" style="font-weight:bold;">Volume 10, No.2, May 2022: 124-137</span></p>
<p><span class="font0" style="font-weight:bold;">E-ISSN: 2654-9182</span></p><a name="caption1"></a>
<h1><a name="bookmark0"></a><span class="font6" style="font-weight:bold;"><a name="bookmark1"></a>TAI CHI ROLES IN REDUCING FATIGUE, PAIN, AND TNF</span><span class="font6">-</span><span class="font7">α </span><span class="font6" style="font-weight:bold;">PLASMA</span><br><br><span class="font6" style="font-weight:bold;"><a name="bookmark2"></a>LEVEL ON BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW</span></h1>
<p><span class="font5">Putri Yekti Budi Asih<sup>1*</sup>, I Putu Edra Putra Indrawan<sup>1</sup>, Vera Pravitasari Susila<sup>1</sup>, Putu Ratna Candra Puspita<sup>1</sup>, Andhika Putri Perdana<sup>1</sup>, Nila Wahyuni<sup>2</sup>, I Putu Gede Adiatmika<sup>2</sup></span></p>
<ul style="list-style:none;"><li>
<p><span class="font3"><sup>1</sup> &nbsp;&nbsp;&nbsp;Magister Program of Biomedical Science Anti Aging Medicine Medical Faculty Universitas Udayana, 80234, Denpasar, Indonesia</span></p></li></ul>
<p><span class="font3"><sup>2</sup>Physiology Department Medical Faculty Universitas Udayana, 80234, Denpasar, Indonesia Email : </span><a href="mailto:putriyekti87@yahoo.co.id"><span class="font3">putriyekti87@yahoo.co.id</span></a></p>
<h2><a name="bookmark3"></a><span class="font4" style="font-weight:bold;"><a name="bookmark4"></a>ABSTRACT</span></h2>
<p><span class="font4">Tai Chi (TC) has been very popular over the last few decades as useful tools for reducing stress and improving health. Survivors of breast cancer (BC) often experience symptoms that reduce their quality of life during and after treatment, such as cognitive dysfunction, fatigue, sleep disturbances, depression, pain, and weight gain. The proinflammatory biomarkers like TNF-</span><span class="font5">α</span><span class="font4">, IL-1, and IL-6 which are activated through the central nervous system were believed to induce fatigue, pain, and other complications that caused hindrance on life activity. The aim of this study is to identify and evaluate the effect of TC training on inflammatory biomarkers, especially TNF-</span><span class="font5">α</span><span class="font4">, pain, and cancer-related fatigue (CRF) in BC patients. Journal searching processes were performed through five electronic databases (ProQuest, Sciencedirect, PubMed, Google Scholar, and Sage Publications) and restricted from 2012 to 2022. The search strategy on the electronic databases was using terms like 'tai ji', 'tai chi', 'tumor necrosis factor-alpha', 'Interleukin-6', 'fatigue', 'pain', 'breast cancer', ‘biomarker’, 'TNF', 'TNF-</span><span class="font5">α</span><span class="font4">', and 'TNF-alpha'. Nine journals were chosen to be reviewed and discussed the intervention of Tai Chi, research methodology, and study results using pain, fatigue, and TNF-</span><span class="font5">α </span><span class="font4">biomarker. Tai Chi seems to be effective to reduce pain, cancer-related fatigue, and improves quality of life for breast cancer patients.</span></p>
<p><span class="font4" style="font-weight:bold;font-style:italic;">Keywords: Tai Chi; breast cancer; TNF-α; Fatigue; Pain</span></p>
<h2><a name="bookmark5"></a><span class="font4" style="font-weight:bold;"><a name="bookmark6"></a>INTRODUCTION</span></h2>
<p><span class="font4">The most frequently diagnosed cancer worldwide according to the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for 2020, especially those found in women, is breast cancer (BC), which is around 2.26 million cases <sup>1</sup>. Careful evaluation and long-term management of side effects is a major challenge from a clinical point of view which is of great importance for BC patients who have undergone chemotherapy and require long-term adjuvant treatment <sup>2</sup>.</span></p>
<p><span class="font4">With early detection and accompanied by advances in the treatment of BC, patients with BC can achieve an increasing percentage of survival and are able to survive longer. With an increase in overall life expectancy, BC survivors who suffer from this disease for a long time are subsequently at risk of accelerated aging, which causes the signs, symptoms of aging and cancer development to overlap. Cancer is also strongly linked with aging <sup>3</sup>. Related to this problem, there have been many epidemiological studies that highlight long-term complications that are closely related, especially with BC treatment. But on the other hand, the underlying molecular mechanisms have not been well elucidated.</span></p>
<p><span class="font4">Treatment for BC includes surgery, chemotherapy, radiation therapy, and hormone therapy, which can be done alone or in combination. Although survival of patients with BC for at least 5 years after diagnosis ranges from over 90% in high-income countries, to 66% in India and 40% in South Africa, side effects after diagnosis and treatment can be persistently debilitating <sup>4</sup>. It is important to pay attention to other things, not</span></p>
<p><span class="font4">only from a clinical perspective after cancer treatment, but also the possibility of recurrence and viability, and treatment effect or cancer itself on physical and mental function as well as the welfare of breast cancer patients. Side effects of breast cancer and its treatment include cancer-related fatigue <sup>5,6</sup>, sleep disturbances</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4"><sup>7</sup>, depression, anxiety <sup>8,9</sup>, chronic pain <sup>10,11</sup>, decreased functional capacity, decreased muscle strength and endurance, and weight gain, which in the end will positively change the quality of life (QOL) <sup>12</sup>.</span></p></li></ul>
<p><span class="font4">Fatigue, particularly, has a negative effect on quality of life, in breast cancer patients and survivors can last 10 years or more <sup>6</sup>. CRF is described as prolonged discomfort with a feeling exhausted and tired that could interfere with daily activities as the symptoms. Control and monitoring on it is required <sup>13,14</sup>. Even though the CRF pathophysiology is still not well-understood, some mechanisms are proposed to explain the CRF development mechanism, such as dysfunction of inflammation and mitochondria, activation of the immune peripheral, and central mechanism <sup>14,15</sup>. BC patients who sense CRF complaints will find elevated levels of pro-inflammatory cytokines, especially Tumor Necrosis Factor-α (TNF-α), interleukin-1 (IL-1), as well as interleukin-6 (IL-6) <sup>16</sup>. CNS (central nervous system) pathways activated by proinflammatory cytokines, such as interleukin-1beta (IL-1β), IL-6 and TNF-α due to cell stress, cell death, chemotherapy, and tumor microenvironment can induce fatigue, pain and other disturbances <sup>12,16,17</sup>. Due to the limitation on conventional therapies, other methods such as complementary and alternative medicine (CAM) were approached by BC survivors and TC started to gain attention <sup>18,19</sup>.</span></p>
<p><span class="font4">TC is a traditional Chinese training in the form of movements that are full of ancient Chinese philosophy and Chinese medicine, such as Confucianism and Taoism. TC is a mind-body exercise that combines breathing exercises, meditation and a series of sequential body movements with coordinated, balance-based postures <sup>20</sup>. TC is often used to improve physical function, strength, balance, and to prevent falls in breast cancer patients <sup>21</sup>. In addition, TC also plays a good role in improving the quality of life (QoL) and improving sleep quality in cancer patients <sup>22–24</sup>. Some possible mechanisms that Tai Chi could relieve fatigue are developing relaxation through slow movement and shifting weight, increasing aerobic capacity, enhancing immune system <sup>13</sup>. The National Comprehensive Cancer Network (NCCN) has proposed a guideline for managing CRF, however the gold standard for CRF has not been decided <sup>13</sup>. Even though several studies show improvement in fatigue and reducing pain as well as reducing TNF-</span><span class="font5">α </span><span class="font4">plasma level, the contrary studies result still remain <sup>13</sup>. Some studies also indicated that no significant changes were made </span><span class="font3"><sub>by TC</sub> </span><span class="font2">18,25–28</span><span class="font3"><sub>.</sub></span></p>
<p><span class="font4">Ten randomized controlled trials have investigated the effect of TC on systemic markers inflammation in noncancerous samples. TC reduces circulating TNF-</span><span class="font5">α </span><span class="font4">levels in patients with COVID-19 <sup>29</sup>, in patients with ankylosing spondylitis <sup>30</sup>, in stroke patients <sup>31,32</sup>, COPD patients <sup>33</sup>, heart failure patients <sup>34,35</sup>. Few of these studies have focused on breast cancer survivors, and almost none have thoroughly reviewed and assessed the effects of TC on inflammation at the cellular level of proinflammatory cytokines (specifically, TNF-</span><span class="font5">α</span><span class="font4">) regarding the mechanisms of their effect on pain and fatigue in breast cancer patients.</span></p>
<h2><a name="bookmark7"></a><span class="font4" style="font-weight:bold;"><a name="bookmark8"></a>METHODS</span></h2>
<ul style="list-style:none;"><li>
<p><span class="font4">a. &nbsp;&nbsp;&nbsp;Methodology</span></p></li></ul>
<p><span class="font4" style="font-style:italic;">Study design</span></p>
<p><span class="font4">This study is a systematic review which was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines <sup>36</sup>. Literature search, literature selection, data extraction, and critical assessment were performed by the five reviewers independently, and any inconsistencies were resolved by mutual agreement or in consultation with a third experienced reviewer.</span></p>
<p><span class="font4" style="font-style:italic;">Subjects recruitment</span></p>
<p><span class="font4">The eligibility criteria for this study were as follows: (a) study design: randomized controlled trials (RCTs), and randomized partially blinded trials; (b) participants: adult patients diagnosed with BC who are receiving active treatment (i.e. surgery, radiation therapy, chemotherapy, or antihormonal</span></p>
<p><span class="font4">therapy); (c) intervention: TC with or without a combination of other interventions; and (d) The control group: other exercise, class meeting, conventional therapy or no treatment at all.</span></p>
<p><span class="font4">The primary outcome of this study was TNF-</span><span class="font5">α </span><span class="font4">measured with ELISA-kit, and for the second outcomes were pain and fatigue. Other results such as repeated publications, review comments, magazine articles, and other types of research were excluded.</span></p>
<p><span class="font4" style="font-style:italic;">Literature Research</span></p>
<p><span class="font4">Five electronic databases (ProQuest, Sciencedirect, PubMed Central NCBI, Google Scholar, and Sage Publications) were searched from 2012 to 2022. Search strategy in English electronic database was compiled using the terms The search strategy on the electronic website used terms from 'tai ji', 'tai chi', 'tumor necrosis factor-alpha', 'interleukin-6', 'fatigue', 'pain', 'breast cancer', ‘biomarker’, 'TNF', 'TNF-</span><span class="font5">α</span><span class="font4">', and 'TNF-alpha'.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4">b. &nbsp;&nbsp;&nbsp;Material and Procedure</span></p></li></ul>
<p><span class="font4">Article searching processes were begun with inserting the keywords to each search engine that was chosen independently by the reviewers to find the literature needed. The next step was excluding the duplications found from the 5 search engines. Title and abstract that qualified the eligibility standard were identified, which next will be assessed by the reviewers. The studies chosen consist of randomized control trials and randomized partially blinded trials with TC exercises that were performed in various times from 20 to 120 minutes per session, with frequency range from once to 5 times a week, over 1-15 months of intervention. These TC practices were under the supervision of experienced TC instructors.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4">c. &nbsp;&nbsp;&nbsp;Assessment</span></p></li></ul>
<p><span class="font4">The reviewers assessed independently by the inclusion criterias and excluded non-representing journals. Then the reviewers analyzed several things from the journal’s contents based on the suitability of topics, indexes or journal ratings through the Scimagojr website with journal criteria that met Q1 and Q2 quality, sample size, results from each journal, and limitations that occurred. The journals that met the criterias would proceed for data extraction.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4">d. &nbsp;&nbsp;&nbsp;Data analysis</span></p></li></ul>
<p><span class="font4">Data extraction was performed by five reviewers from selected studies and independently assessed methodological quality. The extracted information included the authors and the year of publication of the journal, the participants, research purposes, intervention characteristics used in the study (the frequency of exercise and the length of time), the outcome being measured, and study results. If any disagreement arises between the five investigators, the discussion would be organized to propose a solution after reaching an agreement. The third party suggestion would be included if the five reviewers could not reach an agreement.</span></p>
<h2><a name="bookmark9"></a><span class="font4" style="font-weight:bold;"><a name="bookmark10"></a>RESULTS</span></h2>
<p><span class="font4">Reviewers have found 1.557 journals (including duplicates) from five databases. The selection process on several journals were performed according to the relevancy to the title and the article’s abstract. In order to check the journals’ index, investigations through Scimagojr website were conducted.</span></p><img src="https://jurnal.harianregional.com/media/85045-1.jpg" alt="" style="width:350pt;height:330pt;">
<p><span class="font3">Figure 1. Flowchart of the study selection and identification</span></p>
<p><span class="font4">Forty-nine journals were selected for this systematic review. At the end, nine journals were chosen to be explored and discussed in more depth because of the appropriateness of the intervention, research methodology and study results using pain, fatigue and TNF-</span><span class="font5">α </span><span class="font4">biomarker. The data extraction of the nine journals is presented in Table 1.</span></p>
<p><span class="font3">Table 1. Data Extraction of Literature Review Results</span></p>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">No &nbsp;Author,</span></p>
<p><span class="font3" style="font-weight:bold;">Year of Research</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Participant/ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Outcomes &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intervention and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Duration &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Frequency &nbsp;&nbsp;&nbsp;Research &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research Result</span></p>
<p><span class="font3" style="font-weight:bold;">Research &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research Purpose &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(weeks or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Methods</span></p>
<p><span class="font3" style="font-weight:bold;">Groups &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;months)</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">1. &nbsp;&nbsp;&nbsp;Robins</span></p>
<p><span class="font3">et al., 2013 <sup>25</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font3">A total of 109 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Psychosocial &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spiritual growth group &nbsp;&nbsp;&nbsp;&nbsp;10 weeks &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90 minutes &nbsp;&nbsp;&nbsp;&nbsp;Randomized &nbsp;&nbsp;&nbsp;Psychosocial interventions such as TC</span></p>
<p><span class="font3">participants &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;instruments and &nbsp;&nbsp;&nbsp;and TC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per session &nbsp;&nbsp;&nbsp;&nbsp;control trial &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or spiritual growth groups may not</span></p>
<p><span class="font3">immunological by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each week &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;have a significant enough effect to</span></p>
<p><span class="font3">proinflammatory &nbsp;&nbsp;Research purpose: to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;overcome the physiological or</span></p>
<p><span class="font3">cytokines in the &nbsp;&nbsp;&nbsp;evaluate quality of life, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;psychosocial stress experienced by BC</span></p>
<p><span class="font3">acute phase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;psychosocial functioning, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients during the treatment period</span></p>
<p><span class="font3">(TNF-</span><span class="font4">α</span><span class="font3">, IL-1, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and biological markers &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;who generally experience side effects</span></p>
<p><span class="font3">and IL-6) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;thought to reflect cancer- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such as gastrointestinal disturbances,</span></p>
<p><span class="font3">specific mechanisms and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and fatigue.</span></p>
<p><span class="font3">treatment</span></p>
<p><span class="font3">There was a better recovery in the production of proinflammatory cytokines (TNF-</span><span class="font4">α</span><span class="font3">, IL-1, and IL-6) as indicated by an elevation in IFN- □ levels</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">2. &nbsp;&nbsp;&nbsp;Cheng et</span></p>
<p><span class="font3">al., 2021 <sup>37</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font3">120 cancer patients CRF &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Resistance training and &nbsp;&nbsp;&nbsp;12 weeks &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Duration 40 &nbsp;&nbsp;&nbsp;Randomized &nbsp;&nbsp;&nbsp;&nbsp;The study showed a significant</span></p>
<p><span class="font3">aged 55 years or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;minutes per &nbsp;&nbsp;&nbsp;controlled trial &nbsp;&nbsp;improvement on CRF of cancer</span></p>
<p><span class="font3">older; diagnosed &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients in both groups (RT and TC) in</span></p>
<p><span class="font3">with lung, stomach &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research purpose: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 times per &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12 weeks after intervention, better than</span></p>
<p><span class="font3">and breast cancer &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Learning impact of TC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;week. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pre-treatment (P&lt;0.05).</span></p>
<p><span class="font3">histopathologically &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and RT on CRF and QoL</span></p>
<p><span class="font3">; had received 2-4 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in patients diagnosed</span></p>
<p><span class="font3">courses of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with BC, lung, and</span></p>
<p><span class="font3">chemotherapy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;stomach cancer.</span></p>
<p><span class="font3">and/or with additional radiation therapy and with a Brief Fatigue Inventory (BFI) examination showed complaints of CRF.</span></p></td></tr>
</table>
<table border="1">
<tr><td style="vertical-align:bottom;">
<p><span class="font3">3.</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Tsang</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">105 breast cancer</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">white blood cell</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Tai Chi Chuan</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">12 weeks</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">90 minutes</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Randomized-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">No significant changes on cytokines</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">et al., 2015 <sup>28</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">patients aged 32– 42 years that underwent mastectomy for invasive ductal carcinoma and completed 4 cycles of FEC</span></p>
<p><span class="font3">50 healthy female participants, aged 26–36 years.</span></p></td><td style="vertical-align:top;">
<p><span class="font3">(WBC), red blood cell (RBC) count and cytokine levels (IL-2, IL-4, IL-6, IFN-c and TNF-</span><span class="font4">α</span><span class="font3">)</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Research Purpose : explore Tai Chi chuan effects on biological marker and psychological aspect of patients diagnosed with advanced invasive ductal carcinoma</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">3 times per week</span></p></td><td style="vertical-align:top;">
<p><span class="font3">controlled trial</span></p></td><td style="vertical-align:top;">
<p><span class="font3">(IL-2, IL4, IL6, IFN-c and TNF-</span><span class="font4">α</span><span class="font3">) level between patients and healthy groups after 12 months of Tai Chi Chuan.</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">4.</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Larkey et al., 2016 <sup>38</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">250 fatigued, post-menopausal women aged 45 -75 years, diagnosed with breast cancer (stage 0-III), between 6 months and 5 years past primary treatment. postmenopausal status; and 5) current</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Anxiety, fatigue, depression, cognitive function, sleep quality, physical activity</span></p>
<p><span class="font3">Biomarker of HPA axis dysregulation (diurnal cortisol)</span></p>
<p><span class="font3">Inflammation biomarkers (IL-1 Ra, IL-6, TNF-</span><span class="font4">α </span><span class="font3">and INFᵧ)</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Qigong/Tai Chi Easy (QG/TCE), educational support (ES) group, and Qigong group (SQG)</span></p>
<p><span class="font3">Research purpose :</span></p>
<p><span class="font3">Finding Qigong/Tai Chi Easy effects on reducing CRF in BC patients and the following biochemical mechanism</span></p></td><td style="vertical-align:top;">
<p><span class="font3">12 weeks</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Weekly for 1 hour</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Three-armed randomized controlled trial</span></p>
<p><span class="font3">Pre - post intervention</span></p></td><td style="vertical-align:top;">
<p><span class="font3">No significant differences pre and post intervention on cortisol and inflammation biomarkers.</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font3">5.</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Irwin</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">123 breast cancer</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Systemic (CRP</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Cognitive-Behavioral</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">4 months</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">20 minutes</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Randomized</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">This study declared that CBT-I</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">et al., 2015 <sup>39</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">adult older than 55 years who met the criteria for primary insomnia in the DSM-IV</span></p></td><td style="vertical-align:top;">
<p><span class="font3">values), Cellular (TNF-</span><span class="font4">α</span><span class="font3">, TLR-4 activation, and IL-6), Genomic (gene expression)</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Therapy for Insomnia (CBT-I), Tai Chi Chih intervention (TCC), and Sleep seminar education active control condition.</span></p></td><td style="vertical-align:top;">
<p><span class="font3">and followed up in the 7th and 16th month</span></p></td><td style="vertical-align:top;">
<p><span class="font3">class time done every week</span></p></td><td style="vertical-align:top;">
<p><span class="font3">control trial</span></p></td><td style="vertical-align:top;">
<p><span class="font3">improved sleep behavior and reduced CBT-I-induced systemic inflammation. Tai Chi Chih, induced reduction of cellular inflammation, suggesting that this change was independent of sleep quality improvement.</span></p></td></tr>
</table>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font3">6. &nbsp;&nbsp;&nbsp;Irwin et &nbsp;&nbsp;&nbsp;&nbsp;145 BC survivors</span></p>
<p><span class="font3">al., 2017 <sup>40</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">Improve &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tai Chi Chih and CBT-I &nbsp;&nbsp;3-15 months &nbsp;&nbsp;&nbsp;120 minutes &nbsp;&nbsp;Randomized &nbsp;&nbsp;&nbsp;The study conducted with this non<sup>insomnia, boost</sup> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per sessions &nbsp;&nbsp;&nbsp;<sup>partially</sup> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inferiority test showed that TCC was</span></p>
<p><span class="font3">good quality of &nbsp;&nbsp;&nbsp;Research purpose: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;blinded trial &nbsp;&nbsp;&nbsp;&nbsp;<sub>not lower than CBT-I at 3 months,</sub></span></p>
<p><span class="font3">sleep, reduce &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sleep Quality Index to</span></p>
<p><span class="font3">One times &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;which was indicated by the absence of</span></p>
<p><span class="font3">fatigue, and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;evaluate insomnia</span></p>
<p><span class="font3"><sub>depression. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;treatment response and</sub> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per week &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;significant differences between the two</span></p>
<p><span class="font3">fatigue &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>groups.</sup></span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">7. &nbsp;&nbsp;&nbsp;Sprod et &nbsp;&nbsp;&nbsp;35 BC survivors</span></p>
<p><span class="font3">al., 2012</span></p>
<p><span class="font2">41</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Cortisol, insulin, &nbsp;&nbsp;&nbsp;Standard support therapy &nbsp;&nbsp;12 weeks &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60 minutes, &nbsp;&nbsp;&nbsp;Randomized &nbsp;&nbsp;&nbsp;&nbsp;No significant differences in IL-6,</span></p>
<p><span class="font3">glucose, IL-6, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(SST) and Tai Chi Chuan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 times per &nbsp;&nbsp;&nbsp;&nbsp;controlled trial &nbsp;IGF-1, and Body Mass Index.</span></p>
<p><span class="font3">IGF-1, IL-8, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;week</span></p>
<p><span class="font3">insulin-like &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research purpose: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Physical capacity limitations, social</span></p>
<p><span class="font3">growth factor- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To examine the impact of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;well-being, mental health, energy,</span></p>
<p><span class="font3">binding protein &nbsp;&nbsp;&nbsp;&nbsp;TCC based on health- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;significantly better in the TCC group.</span></p>
<p><span class="font3">(IGFBP)-1, and &nbsp;&nbsp;&nbsp;related QoL,</span></p>
<p><span class="font3">IGFBP-3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inflammatory biomarkers &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No significant change in pain,</span></p>
<p><span class="font3">and other biomarkers &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;emotional limitations, and general</span></p>
<p><span class="font3">Quality of life &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;associated with &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;health responses in both groups, SST</span></p>
<p><span class="font3">(includes physical aftereffects of disease &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and TCC.</span></p>
<p><span class="font3">and emotional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and treatment in BC.</span></p>
<p><span class="font3">capacity limitations, mental health, social and physical wellbeing, pain, energy, and general health responses).</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">8. &nbsp;&nbsp;Campo &nbsp;&nbsp;&nbsp;63 women with</span></p>
<p><span class="font3">et al., &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cancer (aged 55 –</span></p>
<p><span class="font3">2015 <sup>42</sup> &nbsp;&nbsp;&nbsp;&nbsp;84 years) who</span></p>
<p><span class="font3">have limited physical function (physical role 72 or SF-12 physical function 80)</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Salivary cortisol, &nbsp;&nbsp;Intervention: Tai Chi and &nbsp;5 to 12 weeks &nbsp;45 minutes - &nbsp;&nbsp;Randomized &nbsp;&nbsp;&nbsp;&nbsp;The results showed no significant</span></p>
<p><span class="font3">BP, anti- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Health Education. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 hours per &nbsp;&nbsp;&nbsp;&nbsp;controlled trial &nbsp;&nbsp;difference between post-intervention</span></p>
<p><span class="font3">inflammatory &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;session &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pro-inflammatory and anticytokines &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research purpose: to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 - 5 times a &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inflammatory cytokines.</span></p>
<p><span class="font3">(IL-12, IL-4, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;examine TC as a mental &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;week &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No interventional effect was seen on</span></p>
<p><span class="font3">IL-6, IL-10, and &nbsp;&nbsp;&nbsp;and physical exercise that &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the levels of inflammatory cytokines,</span></p>
<p><span class="font3">TNF-</span><span class="font4">α</span><span class="font3">) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is associated with &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this is consistent with the results</span></p>
<p><span class="font3">reduced risk factors for &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reported in a previous TC study</span></p>
<p><span class="font3">chronic illness. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;conducted in a group of healthy elderly</span></p>
<p><span class="font3">and elderly with breast cancer.</span></p></td></tr>
</table>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font3">9.</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Irwin</span></p></td><td style="vertical-align:top;">
<p><span class="font3">90 insomnia -</span></p></td><td style="vertical-align:top;">
<p><span class="font3">IL-6 and TNF-</span><span class="font4">α</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Intervention: Tai Chi</span></p></td><td style="vertical-align:top;">
<p><span class="font3">3 months</span></p></td><td style="vertical-align:top;">
<p><span class="font3">2-hour</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Randomized</span></p></td><td style="vertical-align:top;">
<p><span class="font3">This study highlights Tai Chi and other</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font3">et al.,</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">breast cancer</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font3">sessions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">controlled trial</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">mind-body therapy may play a role in</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">2014 <sup>43</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">survivors.</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">Research purpose: This study assumed that Tai Chi (TCC) reduced systemic, cellular, and genomic markers of inflammation compared to cognitive-behavioral therapy (CBT-I) for insomnia in breast cancer survivors.</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">weekly.</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3">the regulation of the immune system, consistent with other findings that psychosomatic therapy and CBSM (cognitive behavioral stress management, help reduce inflammation, including in cancer patients</span></p>
<p><span class="font3">Post-treatment assessments showed reduced TLR4-activated monocyte</span></p></td></tr>
</table>
<p><span class="font3">production of IL6 and TNF-</span><span class="font4">α </span><span class="font3">in cancer survivors treated with TCC.</span></p>
<h2><a name="bookmark11"></a><span class="font4" style="font-weight:bold;"><a name="bookmark12"></a>DISCUSSION</span></h2>
<p><span class="font4">This systematic review describes the procedures and methodology of a ten-year randomized controlled trial, housed in various locations, which will investigate the effectiveness of TC exercise on fatigue, pain and its effect on TNF-</span><span class="font5">α </span><span class="font4">biomarkers in breast cancer patients.</span></p>
<p><span class="font4">Several trials were included in this review, and there was a high risk of bias in the blinding. This literature review analysis was carried out according to the types of TC exercises with different intensities, consisting of 12 weeks with a frequency of 1-3 times per week with a duration of 40 minutes <sup>37</sup>, 60 minutes <sup>38,41</sup>, 90 minutes <sup>28</sup>, 10 weeks with a duration of 90 minutes per session each week <sup>25</sup>, 4 months with a duration of 20 minutes class time done every week <sup>39</sup>, 3 months for 120 minutes per session each week <sup>43</sup>, 3-15 months <sup>40</sup>, 5-12 weeks with a duration of 45 minutes - 2 hours per session and frequency 2 - 5 times a week <sup>42</sup>, 120 minutes per session each week for 3 until 15 months <sup>40</sup>.</span></p>
<p><span class="font4">From existing studies, TC intensity has been shown to have an effect on IL-6 and TNF-</span><span class="font5">α</span><span class="font4">, which results show that high-intensity TC significantly reduces TNF-</span><span class="font5">α </span><span class="font4"><sup>29</sup>.</span></p>
<p><span class="font4">TC has steadily grown in recent decades. It has been shown that this intervention approach to reduce aging symptoms and improve quality is valid. And several recent studies have begun to look for evidence of the influence of TC on biological processes of the body (including the inflammatory response including cellular, circulatory, and genomic marker responses of inflammation), that quantitatively assess the effect of TC on inflammatory markers such as IL-6, TNF-</span><span class="font5">α</span><span class="font4">, CRP, and stimulated cytokine production <sup>27</sup>.</span></p>
<p><span class="font4">Irwin et al emphasizes that TC and other mind-body therapy may play a role in the regulation of the immune system. This is consistent with other findings that psychosomatic therapy and CBSM (cognitive behavioral stress management, help reduce inflammation, including in cancer patients <sup>43</sup>.</span></p><img src="https://jurnal.harianregional.com/media/85045-2.jpg" alt="" style="width:325pt;height:225pt;">
<p><span class="font3">Figure 2. Hypothesis Of Tai Chi Roles In Reducing Fatigue, Pain, And TNF</span><span class="font4">-</span><span class="font5">α </span><span class="font3">Plasma Level On Breast Cancer Patients</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4">a. &nbsp;&nbsp;&nbsp;Tai Chi And Fatigue In Breast Cancer</span></p></li></ul>
<p><span class="font4">Cancer-related fatigue (CRF) is defined as the most common side effect experienced by cancer patients in the form of persistent emotional, physical, and/or cognitive fatigue associated with cancer itself or cancer treatment that can interfere with function and quality of life. Guidelines on fatigue screening and</span></p>
<p><span class="font4">recommendations for intervention based on treatment stage can be studied further in the NCCN Guidelines for Clinical Practice in Oncology. Interventions include counseling and education, common strategies for fatigue management, specific pharmacological and non-pharmacological interventions. Thus, routine screening for identifying CRF is important to ameliorate the quality of life of cancer patients <sup>6,44,45</sup>.</span></p>
<p><span class="font4">Fatigue is a complication that is often underreported, but is considered to be majorly responsible for the decline in quality of life. This CRF has been shown to be a consequence of active treatment, and can be felt until after treatment <sup>44</sup>. Many women with breast cancer report markedly increased fatigue in intensive care patients. Biering et al (2020), conducted a study to describe the process of fatigue in women with breast cancer <sup>46</sup>. The pathophysiological background of fatigue is unknown and its correlation with various biomarkers is weak and still not consistent <sup>47</sup>.</span></p>
<p><span class="font4">The development of CRF is thought to be related to serotonin, adenosine triphosphate and HPA (hypothalamic-pituitary-adrenocortical) axis dysregulation, skeletal muscle shrinkage, desynchronization of circadian rhythms, and cytokines level (especially proinflammatory cytokines). Immune system activation by body injury, trauma, and infection causes proinflammatory cytokine release and other immune factors. These immune factors include soluble receptors, receptor antagonists, and cellular activation products, one of which is TNF-</span><span class="font5">α</span><span class="font4">. These inflammatory cytokines then control local and systemic immune responses. This regulation will mediate neurologic symptoms i.e. fatigue <sup>47</sup>.</span></p>
<p><span class="font4">Therefore, the CRF deserves special review, firstly, because of the demographic relevance of the issue. Fatigue has been considered, not only the most common, but also the most damaging, symptom after treatment for breast cancer patients <sup>45</sup>.</span></p>
<p><span class="font4">The relationship between TC and fatigue was discussed in several literature reviews. Research conducted by Cheng Duan et al (2021) showed that CRF in BC patients improved better than the control group with a TC exercise intervention of 60 minutes per session for 12 weeks <sup>37</sup>. According to Irwin et al (2017) TC exercises provide a significant change in fatigue in breast cancer patients <sup>40</sup>. The same thing is also shown in research conducted by Lisa Sprod and Linda Larkey <sup>38,41</sup>. Whereas in other literature does not show significant changes <sup>25</sup>.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4">b. &nbsp;&nbsp;&nbsp;Tai Chi And Pain In Breast Cancer</span></p></li></ul>
<p><span class="font4">Chronic pain is a common complaint in breast cancer patients and is connected with the release of inflammatory mediators from the tumor, tissue injury, and nerve involvement. This mechanism is the outcome of a network generated by pro-inflammatory cytokines, inflammatory pathway genes and cytokine gene polymorphisms. Breast cancer patients, especially in pre menopausal phase, usually has lower estrogen levels that linked to increased pain as well as impairment of descending pain inhibitory pathways, which may be a risk for developing chronic pain and symptoms such as discomfort and stiffness <sup>48</sup>. According to Sprod et al (2012) in their study that assessing pain as one of the pathological parameters, showed not much improvement-related to BC <sup>41</sup>.</span></p>
<p><span class="font4">There is an explorative study that investigates the effect of TC on β-endorphin, describes that pain and stress may have increased basal β-endorphin and by doing TC could reduce the levels, implying that TC and other physical exercise may increase the capacity of endogenous opioid. But this study also found no significant influence of TC or modest physical activity on inflammatory markers, especially on older adults who suffer from chronic pain <sup>26</sup>.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4">c. &nbsp;&nbsp;&nbsp;Tai Chi And TNF-</span><span class="font5">α </span><span class="font4">Plasma Level In Breast Cancer</span></p></li></ul>
<p><span class="font4">The study conducted by Campo et al showed that the study group had no significant difference between post-intervention pro-inflammatory and anti-inflammatory cytokines <sup>42</sup>. No interventional effect on inflammatory cytokine levels was seen consistent with cytokine results reported in previous TC studies conducted in healthy elderly and breast cancer survivors <sup>49</sup>. The speculation about the finding of nulls is that due to the complex interaction of age-related factors (chronic mild inflammation), the presence of comorbidities, and the late impairment of cancer treatment, TC have older cancer survival. It has a limited effect on a person's inflammatory cytokines. This can lead to immunodeficiency dysregulation <sup>50</sup>.</span></p>
<p><span class="font4">The same result also obtained from the Linda et al and William Tsang et al studies showing that no significant differences caused by TC intervention between pre-post intervention to TNF-</span><span class="font5">α </span><span class="font4">and other biomarkers <sup>28,38</sup>. The same thing is also shown in research conducted by Rebecca Campo <sup>42</sup>. However, a contrary post-treatment assessments by Irwin et al showed reduced TLR4-activated monocyte production of IL-6 and TNF-</span><span class="font5">α </span><span class="font4">in cancer survivors treated with TC Chih <sup>39,43</sup>.</span></p>
<p><span class="font4">Cancer patients have proinflammatory tendencies which could activate the immune system, including releasing inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-</span><span class="font5">α </span><span class="font4">and CRP) but the mechanism of physical exercise in decreasing inflammatory biomarkers is still not clearly understood <sup>51</sup>. Several studies showed inflammatory gene expression was decreased due to MBT (Tai Chi and Yoga) and that statement was supported by the trial results that identified changes in molecular signaling pathway even on trials that showed no significant differences <sup>27</sup>. In spite of that, further studies are required to deeply understand the benefit of TC in downregulation of inflammatory biomarkers.</span></p>
<h2><a name="bookmark13"></a><span class="font4" style="font-weight:bold;"><a name="bookmark14"></a>CONCLUSION</span></h2>
<p><span class="font4">Survivors as well as breast cancer patients, during and after treatment, often experience complaints of fatigue, pain, depression, sleep disturbances, and cognitive dysfunction. There is an increased interest among breast cancer patients and survivors to use mental and physical practices, including Tai Chi, Qigong, Yoga, and other practices. TC is still under-researched but seems promising to increase the ability of physical activity, which adds meditative benefits to cancer survivors and thereby improves survival outcomes.</span></p>
<p><span class="font4">In this systematic review, there are three studies showing that TC had no significant impact on TNF-</span><span class="font5">α </span><span class="font4">plasma levels in breast cancer patients. However, two other studies showed significant impact in reducing TNF-</span><span class="font5">α </span><span class="font4">plasma levels in BC patients. One study showed that TC had no significant impact on pain in breast cancer patients. Two studies showed that TC had a significant impact on fatigue in breast cancer patients, yet one study stated otherwise.</span></p>
<p><span class="font4">These contrary results might be caused by age-related multifactorial condition interactions that impaired inflammatory cytokines function. These conditions possibly lead to no improvement on fatigue and pain. Based on published research, it is still difficult to determine inflammatory biomarkers that are influenced by the frequency, duration and intensity of TC exercise. A clearer comprehension is required of the biological pathways through which TC design was capable of developing a powerful TC intervention to decrease the symptom of breast cancer survivors.</span></p>
<p><span class="font4">This conclusion should be interpreted with more caution because the included journal is limited. Additional randomized controlled trials with more rigorous and precise methodologies accompanied by a lower risk of bias in each study, are needed to provide more accurate evidence. Furthermore, more research is needed in all areas of cancer survival and TC.</span></p>
<h2><a name="bookmark15"></a><span class="font4" style="font-weight:bold;"><a name="bookmark16"></a>CONFLICT OF INTEREST</span></h2>
<p><span class="font4">The authors declare no conflict of interest.</span></p>
<h2><a name="bookmark17"></a><span class="font4" style="font-weight:bold;"><a name="bookmark18"></a>ACKNOWLEDGEMENT</span></h2>
<p><span class="font4">Author would like to thank for the advice, tutoring and consulting guidance from Prof. Dr. dr. I Putu Gede Adiatmika, M.Kes and dr. Nila Wahyuni, M. Fis. And for collaboration of dr. I Putu Edra Putra Indrawan, dr. Andhika Putri Perdana, dr. Putu Ratna Candra, dr. Vera Pravitasari Susila, and dr. Putri Yekti Budi Asih are gratefully acknowledged.</span></p>
<h2><a name="bookmark19"></a><span class="font4" style="font-weight:bold;"><a name="bookmark20"></a>REFERENCES</span></h2>
<ul style="list-style:none;"><li>
<p><span class="font3">1. &nbsp;&nbsp;&nbsp;&nbsp;Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year</span></p></li></ul>
<p><span class="font3">2020: An overview. Int J Cancer. 2021;149(4):778–89.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">2. &nbsp;&nbsp;&nbsp;&nbsp;Moo T, Sanford R, Dang C, Morrow M, Sloan M, Cancer K, et al. Overview of Breast Cancer Therapy. PET</span></p></li></ul>
<p><span class="font3">Clin. 2018;13(3):339–54.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">3. &nbsp;&nbsp;&nbsp;&nbsp;Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31–46.</span></p></li>
<li>
<p><span class="font3">4. &nbsp;&nbsp;&nbsp;&nbsp;WHO. Breast Cancer [Internet]. 2021 [cited 2022 Mar 23]. Available from: </span><a href="https://www.who.int/news-"><span class="font3">https://www.who.int/news-</span></a></p></li></ul>
<p><span class="font3">room/fact-sheets/detail/breast-cancer</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nail L, Portenoy R, Weiss MC. Side Effect: Fatigue [Internet]. Breastcancer.org. 2022 [cited 2022 Mar 23].</span></p></li></ul>
<p><span class="font3">Available from: </span><a href="https://www.breastcancer.org/treatment-side-effects/fatigue"><span class="font3">https://www.breastcancer.org/treatment-side-effects/fatigue</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bower JE. Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol [Internet].</span></p></li></ul>
<p><span class="font3">2014;11(10):597–609. Available from: </span><a href="http://dx.doi.org/10.1038/nrclinonc.2014.127"><span class="font3">http://dx.doi.org/10.1038/nrclinonc.2014.127</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">7. &nbsp;&nbsp;&nbsp;&nbsp;Palesh O, Aldridge-Gerry A, Ulusakarya A, Ortiz-Tudela E, Capuron L, Innominato PF. Sleep disruption in</span></p></li></ul>
<p><span class="font3">breast cancer patients and survivors. JNCCN J Natl Compr Cancer Netw. 2013;11(12):1523–5930.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">8. &nbsp;&nbsp;&nbsp;&nbsp;Tsaras K, Papathanasiou I V., Mitsi D, Veneti A, Kelesi M, Zyga S, et al. Assessment of depression and</span></p></li></ul>
<p><span class="font3">anxiety in breast cancer patients: Prevalence and associated factors. Asian Pacific J Cancer Prev. 2018;19(6):1661–1669.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">9. &nbsp;&nbsp;&nbsp;&nbsp;Naser AY, Hameed AN, Mustafa N, Alwafi H, Dahmash EZ, Alyami HS, et al. Depression and Anxiety in</span></p></li></ul>
<p><span class="font3">Patients With Cancer: A Cross-Sectional Study. Front Psychol. 2021;12:1–12.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">10. &nbsp;&nbsp;&nbsp;Peretti-Watel P, Bendiane MK, Spica L, Rey D. Pain narratives in breast cancer survivors. Pain Res Treat.</span></p></li></ul>
<p><span class="font3">2012;2012:1–8.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">11. &nbsp;&nbsp;&nbsp;Costa WA, Monteiro MN, Queiroz JF, Gonçalves AK. Pain and quality of life in breast cancer patients.</span></p></li></ul>
<p><span class="font3">Clinics. 2017;72(12):758–63.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">12. &nbsp;&nbsp;&nbsp;Perez-Tejada J, Aizpurua-Perez I, Labaka A, Vegas O, Ugartemendia G, Arregi A. Distress, proinflammatory</span></p></li></ul>
<p><span class="font3">cytokines and self-esteem as predictors of quality of life in breast cancer survivors. Physiol Behav [Internet]. 2021;230(2021):113297. Available from: </span><a href="https://doi.org/10.1016/j.physbeh.2020.113297"><span class="font3">https://doi.org/10.1016/j.physbeh.2020.113297</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">13. &nbsp;&nbsp;&nbsp;Xiang Y, Lu L, Chen X, Wen Z. Does Tai Chi relieve fatigue? A systematic review and meta-analysis of</span></p></li></ul>
<p><span class="font3">randomized controlled trials. PLoS One. 2017;12(4):1–22.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">14. &nbsp;&nbsp;&nbsp;Puigpinós-Riera R, Serral G, Sala M, Bargalló X, Quintana MJ, Espinosa M, et al. Cancer-related fatigue and</span></p></li></ul>
<p><span class="font3">its determinants in a cohort of women with breast cancer: the DAMA Cohort. Support Care Cancer. 2020;28(11):5213–21.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">15. &nbsp;&nbsp;&nbsp;Fu HJ, Zhou H, Tang Y, Li J, Zhang D, Ding SY, et al. Tai Chi and other mind-body interventions for cancer-</span></p></li></ul>
<p><span class="font3">related fatigue: An updated systematic review and network meta-analyses protocol. BMJ Open. 2022;12(1):8– 13.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">16. &nbsp;&nbsp;&nbsp;Rogers LQ, M.P.H. AF, Trammell R, Hopkins-Price P, Vicari S, Rao K, et al. Effects of a physical activity</span></p></li></ul>
<p><span class="font3">behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther. 2006;12(4):323–35.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">17. &nbsp;&nbsp;&nbsp;Kwekkeboom KL, Tostrud L, Costanzo E, Coe CL, Serlin RC, Ward SE, et al. The Role of Inflammation in</span></p></li></ul>
<p><span class="font3">the Pain, Fatigue, and Sleep Disturbance Symptom Cluster in Advanced Cancer. J Pain Symptom Manage [Internet]. 2018;55(5):1286–1295. Available from: </span><a href="https://doi.org/10.1016/j.jpainsymman.2018.01.008"><span class="font3">https://doi.org/10.1016/j.jpainsymman.2018.01.008</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">18. &nbsp;&nbsp;&nbsp;Pan Y, Yang K, Shi X, Liang H, Zhang F, Lv Q. Tai Chi Chuan exercise for patients with breast cancer: A</span></p></li></ul>
<p><span class="font3">systematic review and meta-analysis. Evidence-based Complement Altern Med. 2015;2015.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">19. &nbsp;&nbsp;&nbsp;Lo-Fo-Wong DNN, Ranchor A V., de Haes HCJM, Sprangers MAG, Henselmans I. Complementary and</span></p></li></ul>
<p><span class="font3">alternative medicine use of women with breast cancer: Self-help CAM attracts other women than guided CAM therapies. &nbsp;&nbsp;&nbsp;Patient &nbsp;&nbsp;&nbsp;Educ &nbsp;&nbsp;&nbsp;Couns &nbsp;&nbsp;&nbsp;&nbsp;[Internet]. &nbsp;&nbsp;&nbsp;2012;89(3):529–536. &nbsp;&nbsp;&nbsp;Available &nbsp;&nbsp;&nbsp;from:</span></p>
<p><a href="http://dx.doi.org/10.1016/j.pec.2012.02.019"><span class="font3">http://dx.doi.org/10.1016/j.pec.2012.02.019</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">20. &nbsp;&nbsp;&nbsp;Cheng D, Wang B, Li Q, Guo Y, Wang L. Research on Function and Mechanism of Tai Chi on Cardiac</span></p></li></ul>
<p><span class="font3">Rehabilitation. Chin J Integr Med. 2020;26(5):393–400.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">21. &nbsp;&nbsp;&nbsp;Winters-Stone KM, Li F, Horak F, Luoh SW, Bennett JA, Nail L, et al. Comparison of tai chi vs. strength</span></p></li></ul>
<p><span class="font3">training for fall prevention among female cancer survivors: Study protocol for the GET FIT trial. BMC Cancer. 2012;12(577):1–12.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">22. &nbsp;&nbsp;&nbsp;Chen YW, Hunt MA, Campbell KL, Peill K, Reid WD. The effect of Tai Chi on four chronic conditions -</span></p></li></ul>
<p><span class="font3">cancer, osteoarthritis, heart failure and chronic obstructive pulmonary disease: A systematic review and metaanalyses. Br J Sports Med. 2016;50(7):397–407.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">23. &nbsp;&nbsp;&nbsp;Yan JH, Pan L, Zhang XM, Sun CX, Cui GH. Lack of efficacy of tai chi in improving quality of life in breast</span></p></li></ul>
<p><span class="font3">cancer survivors: A systematic review and meta-analysis. Asian Pacific J Cancer Prev. 2014;15(8):3715–3720.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">24. &nbsp;&nbsp;&nbsp;Yang L, Winters-Stone K, Rana B, Cao C, Carlson LE, Courneya KS, et al. Tai Chi for cancer survivors: A</span></p></li></ul>
<p><span class="font3">systematic review toward consensus-based guidelines. Cancer Med. 2021;10(21):7447–7456.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">25. &nbsp;&nbsp;&nbsp;Robins JLW, McCain NL, Elswick RK, Walter JM, Gray DP, Tuck I. Psychoneuroimmunology-based stress</span></p></li></ul>
<p><span class="font3">management during adjuvant chemotherapy for early breast cancer. Evidence-based Complement Altern Med. 2013:1–7.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">26. &nbsp;&nbsp;&nbsp;You T, Ogawa EF. Effects of T’ai Chi on Chronic Systemic Inflammation. J Altern Complement Med.</span></p></li></ul>
<p><span class="font3">2019;25(6):656–658.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">27. &nbsp;&nbsp;&nbsp;Bower JE, Irwin MR. Mind-Body Therapies and Control of Inflammatory Biology: A Descriptive Review.</span></p></li></ul>
<p><span class="font3">Brain, Behav Immunit [Internet]. 2016;51:1–11. Available from: &nbsp;&nbsp;&nbsp;</span><a href="file:///C:/Users/Carla"><span class="font3">file:///C:/Users/Carla</span></a></p>
<p><span class="font3">Carolina/Desktop/Artigos para acrescentar na qualificação/The impact of birth weight on cardiovascular disease risk in the.pdf</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">28. &nbsp;&nbsp;&nbsp;Tsang WWN, Gao KL, Chan KM, Purves S, Macfarlane DJ, Fong SSM. Sitting Tai Chi improves the balance</span></p></li></ul>
<p><span class="font3">control and muscle strength of community-dwelling persons with spinal cord injuries: A pilot study. Evidencebased Complement Altern Med. 2015:1–9.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">29. &nbsp;&nbsp;&nbsp;Shu C, Feng S, Cui Q, Cheng S, Wang Y. Impact Of Tai Chi On CRP, TNF-Alpha And IL-6 In Inflammation:</span></p></li></ul>
<p><span class="font3">A Systematic Review And Meta-Analysis. Ann Palliat Med. 2021;10(7):7468–7478.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">30. &nbsp;&nbsp;&nbsp;Cetin SY, Calik BB, Ayan A, Kabul EG. The Effectiveness Of 10-Tai Chi Movements In Patients With</span></p></li></ul>
<p><span class="font3">Ankylosing Spondylitis Receiving Anti-Tumor Necrosis Factor Therapy: A Randomized Controlled Trial. Eur J Integr Med [Internet]. 2020;39:101208. Available from: </span><a href="https://doi.org/10.1016/j.eujim.2020.101208"><span class="font3">https://doi.org/10.1016/j.eujim.2020.101208</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">31. &nbsp;&nbsp;&nbsp;Morawin B, Tylutka A, Chmielowiec J, Zembron-Lacny A. Circulating Mediators Of Apoptosis And</span></p></li></ul>
<p><span class="font3">Inflammation In Aging; Physical Exercise Intervention. Int J Environ Res Public Health. 2021;18(6):1–18.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">32. &nbsp;&nbsp;&nbsp;Taylor-Piliae RE, Morrison HW, Hsu CH, Whitman S, Grandner M. The Feasibility of Tai Chi Exercise as a</span></p></li></ul>
<p><span class="font3">Beneficial Mind-Body Intervention in a Group of Community-Dwelling Stroke Survivors with Symptoms of Depression. Evidence-based Complement Altern Med. 2021;2021.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">33. &nbsp;&nbsp;&nbsp;Gilliam EA, Cheung T, Kraemer K, Litrownik D, Wayne PM, Moy ML, et al. The impact of Tai Chi and</span></p></li></ul>
<p><span class="font3">mind-body breathing in COPD: Insights from a qualitative sub-study of a randomized controlled trial. PLoS One [Internet]. 2021;16(4 April):1–17. Available from: </span><a href="http://dx.doi.org/10.1371/journal.pone.0249263"><span class="font3">http://dx.doi.org/10.1371/journal.pone.0249263</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">34. &nbsp;&nbsp;&nbsp;Luberto CM, Coey CA, Davis RB, Wayne PM, Crute S, Yeh GY. Exploring correlates of improved depression</span></p></li></ul>
<p><span class="font3">symptoms and quality of life following tai chi exercise for patients with heart failure. ESC Hear Fail. 2020;7(6):4206–12.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">35. &nbsp;&nbsp;&nbsp;Redwine LS, Pung MA, Wilson K, Bangen KJ, Delano-Wood L, Hurwitz B. An exploratory randomized sub</span></p></li></ul>
<p><span class="font3">study of light-to-moderate intensity exercise on cognitive function, depression symptoms and inflammation in older adults with heart failure. J Psychosom Res [Internet]. 2020;128(November 2019):109883. Available from: </span><a href="https://doi.org/10.1016/j.jpsychores.2019.109883"><span class="font3">https://doi.org/10.1016/j.jpsychores.2019.109883</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">36. &nbsp;&nbsp;&nbsp;Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020</span></p></li></ul>
<p><span class="font3">statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:1–11.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">37. &nbsp;&nbsp;&nbsp;Cheng D, Wang X, Hu J, Dai L li, Lv Y, Feng H, et al. Effect of Tai Chi and Resistance Training on Cancer-</span></p></li></ul>
<p><span class="font3">Related Fatigue and Quality of Life in Middle-Aged and Elderly Cancer Patients. Chin J Integr Med. 2021;27(4):265–72.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">38. &nbsp;&nbsp;&nbsp;Larkey L, Huberty J, Pedersen M, Weihs K. Qigong/Tai Chi Easy for fatigue in breast cancer survivors:</span></p></li></ul>
<p><span class="font3">Rationale and design of a randomized clinical trial. Contemp Clin Trials [Internet]. 2016;50:222–8. Available from: </span><a href="http://dx.doi.org/10.1016/j.cct.2016.08.002"><span class="font3">http://dx.doi.org/10.1016/j.cct.2016.08.002</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">39. &nbsp;&nbsp;&nbsp;Irwin MR, Olmstead R, Breen EC, Witarama T, Carrillo C, Sadeghi N, et al. Cognitive Behavioral Therapy</span></p></li></ul>
<p><span class="font3">and Tai Chi Reverse Cellular and Genomic Markers of Inflammation in Late-Life Insomnia: A Randomized Controlled Trial. Biol Psychiatry [Internet]. 2015;78(10):721–9. Available from: </span><a href="http://dx.doi.org/10.1016/j.biopsych.2015.01.010"><span class="font3">http://dx.doi.org/10.1016/j.biopsych.2015.01.010</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">40. &nbsp;&nbsp;&nbsp;Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Nicassio P, Ganz PA, et al. Tai Chi Chih compared with</span></p></li></ul>
<p><span class="font3">cognitive behavioral therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A randomized, partially blinded, noninferiority trial. J Clin Oncol. 2017;35(23):2656–65.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">41. &nbsp;&nbsp;&nbsp;Sprod LK, Janelsins MC, Palesh OG, Carroll JK, Heckler CE, Peppone LJ, et al. Health-related quality of life</span></p></li></ul>
<p><span class="font3">and biomarkers in breast cancer survivors participating in tai chi chuan. J Cancer Surviv. 2012;6(2):146–54.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">42. &nbsp;&nbsp;&nbsp;Campo RA, Light KC, O’Connor K, Nakamura Y, Lipschitz D, LaStayo PC, et al. Blood pressure, salivary</span></p></li></ul>
<p><span class="font3">cortisol, and inflammatory cytokine outcomes in senior female cancer survivors enrolled in a tai chi chih randomized controlled trial. J Cancer Surviv. 2015;9(1):115–25.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">43. &nbsp;&nbsp;&nbsp;Irwin MR, Olmstead R, Breen EC, Witarama T, Carrillo C, Sadeghi N, et al. Tai Chi, cellular inflammation,</span></p></li></ul>
<p><span class="font3">and transcriptome dynamics in breast cancer survivors with insomnia: A randomized controlled trial. J Natl Cancer Inst - Monogr. 2014;(50):295–301.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">44. &nbsp;&nbsp;&nbsp;Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-Related</span></p></li></ul>
<p><span class="font3">Fatigue. Version 2.2015: Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2013;65(2):75–8.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">45. &nbsp;&nbsp;&nbsp;Ruiz-Casado A, Álvarez-Bustos A, de Pedro CG, Méndez-Otero M, Romero-Elías M. Cancer-Related Fatigue</span></p></li></ul>
<p><span class="font3">in Breast Cancer Survivors: A Review. Clin Breast Cancer [Internet]. 2021;21(1):10–25. Available from: </span><a href="https://doi.org/10.1016/j.clbc.2020.07.011"><span class="font3">https://doi.org/10.1016/j.clbc.2020.07.011</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">46. &nbsp;&nbsp;&nbsp;Biering K, Frydenberg M, Pappot H, Hjollund NH. The long-term course of fatigue following breast cancer</span></p></li></ul>
<p><span class="font3">diagnosis. J Patient-Reported Outcomes. 2020;4(1).</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">47. &nbsp;&nbsp;&nbsp;Savina S, Zaydiner B. Cancer-Related Fatigue: Some Clinical Aspects. Asia-Pacific J Oncol Nurs.</span></p></li></ul>
<p><span class="font3">2019;6(1):7–9.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">48. &nbsp;&nbsp;&nbsp;Panis C, Pavanelli WR. Cytokines as mediators of pain-related process in breast cancer. Mediators Inflamm.</span></p></li></ul>
<p><span class="font3">2015;2015.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">49. &nbsp;&nbsp;&nbsp;Irwin MR, Olmstead R. Mitigating cellular inflammation in older adults: A randomized controlled trial of Tai</span></p></li></ul>
<p><span class="font3">Chi Chih. Am J Geriatr Psychiatry [Internet]. 2012;20(9):764–72. Available from: </span><a href="http://dx.doi.org/10.1097/JGP.0b013e3182330fd3"><span class="font3">http://dx.doi.org/10.1097/JGP.0b013e3182330fd3</span></a></p>
<ul style="list-style:none;"><li>
<p><span class="font3">50. &nbsp;&nbsp;&nbsp;Woods JA, Wilund KR, Martin SA, Kistler BM. Exercise, inflammation and aging. Aging Dis. 2012;3(1):130–</span></p></li></ul>
<p><span class="font3">40.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font3">51. &nbsp;&nbsp;&nbsp;de Jesus Leite MAF, Puga GM, Arantes FJ, Oliveira CJF, Cunha LM, Bortolini MJS, et al. Effects of combined</span></p></li></ul>
<p><span class="font3">and resistance training on the inflammatory profile in breast cancer survivors: A systematic review. Complement Ther Med. 2018;36(December 2017):73–81.</span></p>
<p><span class="font1">137</span></p>